1
|
Charfi R, Mizouri R, Sassi MB, Gaies E, Eljebari H, Jebabli N, Zereï S, Salem FB, Said DB, Klouz A, Daghfous R, Salouage I, Trabelsi S. [Antiepileptic drugs administration by nasogastric tube in comatose patients]. Therapie 2017; 73:223-230. [PMID: 29126634 DOI: 10.1016/j.therap.2017.08.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2017] [Revised: 08/05/2017] [Accepted: 08/31/2017] [Indexed: 10/18/2022]
Abstract
AIM To evaluate the modalities of administration of antiepileptic drugs (AED) with nasogastric tube (NGT) by nurses and to draw up recommendations. METHODS Our study consisted on investigating the modalities of administration of AED's with NGT by nurses during four months. We prepared 10 questions including demographic information. Participation was voluntary and anonymous. The questionnaire was distributed in seven intensive care departments after authorization of each head of the department. Thus, 45 nurses were included. RESULTS Nurses sex ratio was 1.5 and mean age was 31 years (25 to 37 years). Among the nurses, 60% mentioned that the NGT were silicone made and 4% that they were PVC made. The mean duration before replacing the NGT was thought to be 5±3 days. Among the nurses, 91% affirmed to clear the NGT after each use. All the nurses had agreed that the solid form is the most commonly used pharmaceutical form in the NGT. AED were associated with the enteral feeding solution in 56%. The AED should be crushed before administration for 98% of the nurses even in case of polymedication. Among them, 62% recommended to crush all of the associated drugs together. Before introducing the AED into the NGT, 93% of the nurses reported mixing with tap water. We have noticed that 62% of nurses felt the need to improve their knowledge AED administration with NGT. CONCLUSION To optimize AED therapy, modalities of administration by NGT in epileptic comatose patients should be enhanced.
Collapse
Affiliation(s)
- Rim Charfi
- Service de pharmacologie clinique, centre national de pharmacovigilance, faculté de médecine de Tunis, université de Tunis El Manar, 9, avenue Dr Zouheïr Essafi, 1006 Tunis, Tunisie; Laboratoire de recherche pharmacologie clinique et expérimentale LR16SP02, 1006 Tunis, Tunisie.
| | - Ramla Mizouri
- Service de pharmacologie clinique, centre national de pharmacovigilance, faculté de médecine de Tunis, université de Tunis El Manar, 9, avenue Dr Zouheïr Essafi, 1006 Tunis, Tunisie; Laboratoire de recherche pharmacologie clinique et expérimentale LR16SP02, 1006 Tunis, Tunisie
| | - Mouna Ben Sassi
- Service de pharmacologie clinique, centre national de pharmacovigilance, faculté de médecine de Tunis, université de Tunis El Manar, 9, avenue Dr Zouheïr Essafi, 1006 Tunis, Tunisie; Laboratoire de recherche pharmacologie clinique et expérimentale LR16SP02, 1006 Tunis, Tunisie
| | - Emna Gaies
- Service de pharmacologie clinique, centre national de pharmacovigilance, faculté de médecine de Tunis, université de Tunis El Manar, 9, avenue Dr Zouheïr Essafi, 1006 Tunis, Tunisie; Laboratoire de recherche pharmacologie clinique et expérimentale LR16SP02, 1006 Tunis, Tunisie
| | - Hanene Eljebari
- Service de pharmacologie clinique, centre national de pharmacovigilance, faculté de médecine de Tunis, université de Tunis El Manar, 9, avenue Dr Zouheïr Essafi, 1006 Tunis, Tunisie; Laboratoire de recherche pharmacologie clinique et expérimentale LR16SP02, 1006 Tunis, Tunisie
| | - Nadia Jebabli
- Service de pharmacologie clinique, centre national de pharmacovigilance, faculté de médecine de Tunis, université de Tunis El Manar, 9, avenue Dr Zouheïr Essafi, 1006 Tunis, Tunisie; Laboratoire de recherche pharmacologie clinique et expérimentale LR16SP02, 1006 Tunis, Tunisie
| | - Sarrah Zereï
- Service de pharmacologie clinique, centre national de pharmacovigilance, faculté de médecine de Tunis, université de Tunis El Manar, 9, avenue Dr Zouheïr Essafi, 1006 Tunis, Tunisie
| | - Fatma Ben Salem
- Service de pharmacologie clinique, centre national de pharmacovigilance, faculté de médecine de Tunis, université de Tunis El Manar, 9, avenue Dr Zouheïr Essafi, 1006 Tunis, Tunisie
| | - Dorra Ben Said
- Service de pharmacologie clinique, centre national de pharmacovigilance, faculté de médecine de Tunis, université de Tunis El Manar, 9, avenue Dr Zouheïr Essafi, 1006 Tunis, Tunisie; Laboratoire de recherche pharmacologie clinique et expérimentale LR16SP02, 1006 Tunis, Tunisie
| | - Anis Klouz
- Service de pharmacologie clinique, centre national de pharmacovigilance, faculté de médecine de Tunis, université de Tunis El Manar, 9, avenue Dr Zouheïr Essafi, 1006 Tunis, Tunisie; Laboratoire de recherche pharmacologie clinique et expérimentale LR16SP02, 1006 Tunis, Tunisie
| | - Riadh Daghfous
- Service de pharmacologie clinique, centre national de pharmacovigilance, faculté de médecine de Tunis, université de Tunis El Manar, 9, avenue Dr Zouheïr Essafi, 1006 Tunis, Tunisie; Laboratoire de recherche pharmacologie clinique et expérimentale LR16SP02, 1006 Tunis, Tunisie
| | - Issam Salouage
- Service de pharmacologie clinique, centre national de pharmacovigilance, faculté de médecine de Tunis, université de Tunis El Manar, 9, avenue Dr Zouheïr Essafi, 1006 Tunis, Tunisie; Laboratoire de recherche pharmacologie clinique et expérimentale LR16SP02, 1006 Tunis, Tunisie
| | - Sameh Trabelsi
- Service de pharmacologie clinique, centre national de pharmacovigilance, faculté de médecine de Tunis, université de Tunis El Manar, 9, avenue Dr Zouheïr Essafi, 1006 Tunis, Tunisie; Laboratoire de recherche pharmacologie clinique et expérimentale LR16SP02, 1006 Tunis, Tunisie
| |
Collapse
|